METERED-DOSE INHALERS AND CFCS - WHAT RESPIRATORY PHYSICIANS NEED TO KNOW

被引:36
作者
PARTRIDGE, MR
机构
关键词
D O I
10.1016/S0954-6111(05)80060-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:645 / 647
页数:3
相关论文
共 9 条
[1]   THE ASSESSMENT AND TREATMENT OF ASTHMA - A CONFERENCE REPORT [J].
HARGREAVE, FE ;
DOLOVICH, J ;
NEWHOUSE, MT .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (06) :1098-1111
[2]   COMPLIANCE WITH INHALED THERAPY AND MORBIDITY FROM ASTHMA [J].
HORN, CR ;
CLARK, TJH ;
COCHRANE, GM .
RESPIRATORY MEDICINE, 1990, 84 (01) :67-70
[3]   OZONE DEPLETION AND THE IMMUNE-SYSTEM [J].
JEEVAN, A ;
KRIPKE, ML .
LANCET, 1993, 342 (8880) :1159-1160
[4]   STRATOSPHERIC OZONE DEPLETION [J].
LLOYD, SA .
LANCET, 1993, 342 (8880) :1156-1158
[5]  
ROWLAND FS, 1974, NATURE, V249, P810
[6]   EFFECTS OF HIGH-DOSE INHALED BECLOMETHASONE DIPROPIONATE, 750-MU-G AND 1500-MU-G TWICE-DAILY, AND 40-MG PER DAY ORAL PREDNISOLONE ON LUNG-FUNCTION, SYMPTOMS, AND BRONCHIAL HYPERRESPONSIVENESS IN PATIENTS WITH NONASTHMATIC CHRONIC AIR-FLOW OBSTRUCTION [J].
WEIR, DC ;
BURGE, PS .
THORAX, 1993, 48 (04) :309-316
[7]  
1993, THORAX, V48, pS1
[8]  
1993, BRIT MED J, V306, P776
[9]  
1992, 923991 NAT HEART LUN